BRCA2 and kidney cancer: Testing of interactions between BRCA2 and miR-19a/miR-19b in 15 cell lines derived from pancreatic, breast, colon, and kidney cancers showed that overexpression of these two miRNAs reduced BRCA2 expression by directly binding to its 3′-UTR [23].